ALB and glomerulosclerosis: Compared to the vehicle control mice, Ac-FLTD-CMK-treated MRL/lpr mice had a lower urine albumin-creatinine ratio (Figure 5A), a lower serum creatinine concentration (Figure 5B), reduced glomerulosclerosis (Figure 5C) and CD3, CD4 and CD68 positive cell infiltration (Figure 5D).